Hult, Sara http://orcid.org/0000-0002-9543-7365
Sartori, Daniele http://orcid.org/0000-0003-3634-0317
Bergvall, Tomas
Hedfors Vidlin, Sara http://orcid.org/0000-0003-1619-3751
Grundmark, Birgitta http://orcid.org/0000-0002-2799-9374
Ellenius, Johan
Norén, G. Niklas http://orcid.org/0000-0002-4595-230X
Article History
First Online: 17 July 2020
Compliance with Ethical Standards
:
: No funding was received to conduct this study.
: Sara Hult, Daniele Sartori, Tomas Bergvall, Sara Hedfors Vidlin, Birgitta Grundmark, Johan Ellenius and G. Niklas Norén have no conflicts of interest that are directly relevant to the contents of this study.
: The datasets generated and analysed during the current study are not publicly available due to agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the WHO Programme for International Drug Monitoring contribute data to VigiBase, and Uppsala Monitoring Centre is the custodian in its capacity as the WHO Collaborating Centre for International Drug Monitoring. Some subsets of the data may be available from the corresponding author upon reasonable request.